Co-Diagnostics, Inc.
CODX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -42.5% | -80.1% | -65% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 74.5% | 38.6% | 84% | 88.2% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -988.6% | -608.9% | -30.1% | 47.4% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -961.4% | -518.7% | -41.6% | 37.5% |
| EPS Diluted | -1.24 | -1.2 | -0.45 | 1.23 |
| % Growth | -3.3% | -166.7% | -136.6% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |